213 related articles for article (PubMed ID: 8564990)
1. Intestinal obstruction.
Baines MJ
Cancer Surv; 1994; 21():147-56. PubMed ID: 8564990
[TBL] [Abstract][Full Text] [Related]
2. Malignant irreversible intestinal obstruction: the powerful association of octreotide to corticosteroids, antiemetics, and analgesics.
Weber C; Zulian GB
Am J Hosp Palliat Care; 2009; 26(2):84-8. PubMed ID: 19088264
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.
Jatoi A; Podratz KC; Gill P; Hartmann LC
J Support Oncol; 2004; 2(4):323-34; discussion 334-7. PubMed ID: 15357517
[TBL] [Abstract][Full Text] [Related]
4. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial.
Mystakidou K; Tsilika E; Kalaidopoulou O; Chondros K; Georgaki S; Papadimitriou L
Anticancer Res; 2002; 22(2B):1187-92. PubMed ID: 12168923
[TBL] [Abstract][Full Text] [Related]
5. Aggressive pharmacological treatment for reversing malignant bowel obstruction.
Mercadante S; Ferrera P; Villari P; Marrazzo A
J Pain Symptom Manage; 2004 Oct; 28(4):412-6. PubMed ID: 15471659
[TBL] [Abstract][Full Text] [Related]
6. Management of malignant bowel obstruction.
Ripamonti CI; Easson AM; Gerdes H
Eur J Cancer; 2008 May; 44(8):1105-15. PubMed ID: 18359221
[TBL] [Abstract][Full Text] [Related]
7. Surgery for the palliation of intestinal obstruction in advanced abdominal malignancy.
Wong TH; Tan YM
Singapore Med J; 2009 Dec; 50(12):1139-44. PubMed ID: 20087548
[TBL] [Abstract][Full Text] [Related]
8. Management of bowel obstruction in advanced cancer.
Ripamonti C
Curr Opin Oncol; 1994 Jul; 6(4):351-7. PubMed ID: 7528546
[TBL] [Abstract][Full Text] [Related]
9. Octreotide in the management of bowel obstruction in terminal ovarian cancer.
Mangili G; Franchi M; Mariani A; Zanaboni F; Rabaiotti E; Frigerio L; Bolis PF; Ferrari A
Gynecol Oncol; 1996 Jun; 61(3):345-8. PubMed ID: 8641613
[TBL] [Abstract][Full Text] [Related]
10. [Intestinal occlusion in cancer].
Medina-Franco H
Rev Gastroenterol Mex; 2004 Nov; 69 Suppl 3():100-5. PubMed ID: 16881208
[TBL] [Abstract][Full Text] [Related]
11. Management of intestinal obstruction in patients with advanced cancer.
Baines MJ
Ann Acad Med Singap; 1994 Mar; 23(2):178-82. PubMed ID: 7521607
[TBL] [Abstract][Full Text] [Related]
12. Multicenter prospective study on efficacy and safety of octreotide for inoperable malignant bowel obstruction.
Hisanaga T; Shinjo T; Morita T; Nakajima N; Ikenaga M; Tanimizu M; Kizawa Y; Maeno T; Shima Y; Hyodo I
Jpn J Clin Oncol; 2010 Aug; 40(8):739-45. PubMed ID: 20410056
[TBL] [Abstract][Full Text] [Related]
13. How to use octreotide for malignant bowel obstruction.
Ripamonti C; Mercadante S
J Support Oncol; 2004; 2(4):357-64. PubMed ID: 15357519
[No Abstract] [Full Text] [Related]
14. [Management of bowel obstruction in advanced abdominal or pelvic cancer].
Denis B; Ollier JC
Gastroenterol Clin Biol; 2002 Apr; 26(4):372-85. PubMed ID: 12070413
[No Abstract] [Full Text] [Related]
15. Pharmacological treatment of bowel obstruction in cancer patients.
O'Connor B; Creedon B
Expert Opin Pharmacother; 2011 Oct; 12(14):2205-14. PubMed ID: 21714777
[TBL] [Abstract][Full Text] [Related]
16. [A clinical study using octreotide in relieving gastrointestinal symptoms due to bowel obstruction in a terminally ill cancer patient].
Shima Y; Yamaguchi K; Miyata Y; Hyodo I; Yagi Y; Honke Y
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1377-82. PubMed ID: 15446560
[TBL] [Abstract][Full Text] [Related]
17. Management of symptoms due to inoperable bowel obstruction.
Ripamonti C; Fagnoni E; Magni A
Tumori; 2005; 91(3):233-6. PubMed ID: 16206646
[TBL] [Abstract][Full Text] [Related]
18. Management of bowel obstruction in advanced and terminal cancer patients.
Ripamonti C; De Conno F; Ventafridda V; Rossi B; Baines MJ
Ann Oncol; 1993 Jan; 4(1):15-21. PubMed ID: 8435356
[TBL] [Abstract][Full Text] [Related]
19. Medical management of intestinal obstruction in patients with advanced malignant disease. A clinical and pathological study.
Baines M; Oliver DJ; Carter RL
Lancet; 1985 Nov; 2(8462):990-3. PubMed ID: 2414614
[TBL] [Abstract][Full Text] [Related]
20. The role of octreotide in malignant bowel obstruction.
Krammer LM
Oncol Nurs Forum; 1999 Jun; 26(5):831-2. PubMed ID: 10382174
[No Abstract] [Full Text] [Related]
[Next] [New Search]
